Pancreatic bicarbonate response to intraduodenal tryptophan in dogs
- 19 Downloads
Activation of cholecystokinin-receptors is needed for an adequate pancreatic bicarbonate response to secretin;
Cholinergic nerve fibers ending on M1-receptors are probably of little or no importance for the bicarbonate response to secretin in the given dose;
The bicarbonate response to tryptophan, given with a secretin background, is controlled by cholinergic M1-fibers and by cholecystokinin;
M1-fibers mainly mediate the bicarbonate response to low loads of tryptophan, whereas cholecystokinin controls the response to low and high loads of tryptophan; and
Both mediators interact in a synergistic manner.
In six conscious dogs with chronic gastric and duodenal fistulas, we compared the action of the M1-receptor antagonisttelenzepine (20.25–81.0 nmol/kg/h), the cholecystokinin-receptor antagonist L-364,718 (0.025–0.1 mg/kg/h), and combinations of both on the pancreatic bicarbonate response to graded loads of intraduodenal tryptophan (0.37–10.0 mmol/h), given against a background of secretin (20.5 pmol/kg/h).
Secretin significantly (p<0.05) stimulated the pancreatic bicarbonate output above basal levels. All doses of L-374,718, but not telenzepine, significantly decreased the bicarbonate response to secretin by up to 64%. Additional administration of telenzepine together with L-364,718 had no further inhibitory effect on the secretinstimulated bicarbonate output as compared to L-364,718 given alone. All loads of tryptophan significantly increased the bicarbonate output over that seen with secretin alone (= incremental bicarbonate response to tryptophan). Telenzepine significantly decreased the incremental bicarbonate response to the two lower loads (0.37–1.1 mmol/h) of tryptophan (by 82–124%); L-364,718 decreased the incremental bicarbonate response to all loads of tryptophan (by 50–118%). The incremental bicarbonate output, as well as the 180-min integrated bicarbonate response to all loads of tryptophan, were abolished by all combinations of both antagonists.
Key WordsCholecystokinin dog L-364,718 M1-receptor pancreatic bicarbonate secretion telenzepine
Unable to display preview. Download preview PDF.
- 15.Niebergall-Roth E, Teyssen S, Wetzel D, Hartel M, Beglinger C, Riepl RL, Singer MV. Comparison of the effects of two cholecystokinin-receptor antagonists, loxiglumide and L-364,718, on the pancreatic secretory response to intraduodenal tryptophan in dogs.Scand J Gastroenterol 1996; 31: 723–732.PubMedCrossRefGoogle Scholar
- 16.Singer MV, Solomon TE, Grossman MI. Pancreatic response to intestinal perfusion with tryptophan and phenylalanine.Gastroenterology 1976; 76: 124.Google Scholar
- 17.Thomas JE. An improved cannula for gastric and intestinal fistulas.Proc Soc Exp Biol Med 1941; 46: 260,261.Google Scholar
- 19.Riepl RL, Beier G, Auernhammer CJ, Schopohl J, Hotz E, Petrovitsch M, Lehnert P. Actions of atropine and loperamide on meal-stimulated pancreatic polypeptide and cholecystokinin release in man, inGastrointestinal Tract and Endocrine System, Singer MV, Ziegler R, Rohr G, eds. Kluwer, Dordrecht 1995; pp. 476–481.Google Scholar
- 26.Niebergall-Roth E, Teyssen S, Wetzel D, Hartel M, Beglinger C, Riepl RL, Singer MV. Effects of the M1-receptorantagonist telenzepine and the CCK-receptor antagonist L-364,718 on the pancreatic secretory response to intraduodenal tryptophan before and after truncal vagotomy in dogs.Am J Physiol 1997; 272: G1550-G1559.PubMedGoogle Scholar
- 29.Miller LJ. Heterogenity of CCK receptors: classification and characterization, inCholecystokinin Antagonists in Gastroenterology, Adler G, Beglinger C, eds. Springer, Berlin 1991; pp. 27–34.Google Scholar
- 31.Singer MV, Niebel W, Jansen JBMJ, Hoffmeister D, Gotthold S, Goebell H, Lamers CBHW. Pancreatic secretory response to intravenous cerulein and intraduodenal tryptophan studies: before and after stepwise removal of the extrinsic nerves of the pancreas in dogs.Gastroenterology 1989; 96: 925–934.PubMedGoogle Scholar
- 32.Thor P, Laskiewicz J, Konturek P, Konturek SJ. Cholecystokinin in the regulation of intestinal motility and pancreatic secretion in dogs.Am J Physiol 1988; 255: G489–504.Google Scholar